Seagen Inc (NASDAQ: SGEN) announced that the Phase 3 HER2CLIMB-02 clinical trial of Tukysa (tucatinib) in combination with the antibody-drug conjugate ado-trastuzumab emtansine (Kadcyla) met its primary endpoint of
In an exclusive interview with Frank Cheng, founder of Foonie Magus, Benzinga gained unprecedented insight into Apeiron, the first-ever Web3 god game, and its evolutionary journey. Cheng shared his vision for the game's transition from Web2 to Web3, the strategic launch of the ecosystem token APRS, and Apeiron's appeal to competitive gamers.
Shytoshi Kusama, the mysterious lead developer and co-founder of the Shiba Inu (CRYPTO: SHIB) project, shared intriguing updates from his Middle East trip, sparking curiosity among the memecoin’s fanbase.